These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 7509088)

  • 41. Human immunodeficiency virus infection as risk factor for mother-to-child hepatitis C virus transmission; persistence of anti-hepatitis C virus in children is associated with the mother's anti-hepatitis C virus immunoblotting pattern.
    Manzini P; Saracco G; Cerchier A; Riva C; Musso A; Ricotti E; Palomba E; Scolfaro C; Verme G; Bonino F
    Hepatology; 1995 Feb; 21(2):328-32. PubMed ID: 7843701
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Post-transfusion hepatitis: impact of non-A, non-B hepatitis surrogate tests. Canadian Post-Transfusion Hepatitis Prevention Study Group.
    Blajchman MA; Bull SB; Feinman SV
    Lancet; 1995 Jan; 345(8941):21-5. PubMed ID: 7528310
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prevalence of hepatitis C infection in a hemodialysis unit.
    Colombo P; Filiberti O; Porcu M; Costantini L; Mangione A; Monzeglio C; Peona C
    Nephron; 1992; 61(3):326-7. PubMed ID: 1323782
    [TBL] [Abstract][Full Text] [Related]  

  • 44. High prevalence of antibodies to hepatitis C virus in three haemodialysis centres in south-western Poland.
    Hruby Z; Sliwiński J; Molin I; Zalewska M; Knysz B; Czyz W; Steciwko A; Bogucki J; Gładysz A
    Nephrol Dial Transplant; 1993; 8(8):740-3. PubMed ID: 7692355
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prevalence of hepatitis C viral antibody in transfused and nontransfused Egyptian children.
    Khalifa AS; Mitchell BS; Watts DM; el-Samahy MH; el-Sayed MH; Hassan NF; Jennings GB; Hibbs RG; Corwin AL
    Am J Trop Med Hyg; 1993 Sep; 49(3):316-21. PubMed ID: 7690525
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Significance of alanine aminotransferase screening in blood donors for risk reduction of hepatitis B and C transmission by haemotherapy].
    Kusendová K; Gavorník P; Sabaka P; Sviteková K
    Vnitr Lek; 2016 Jan; 62(1):9-16. PubMed ID: 26967232
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antibodies to hepatitis C virus: a cross-sectional study in patients attending a trauma unit or admitted to hospital for elective surgery.
    García-Bengoechea M; Emparanza JI; Sarriugarte A; Cortés A; Vega JL; González F; Arenas JI
    Eur J Gastroenterol Hepatol; 1995 Mar; 7(3):237-41. PubMed ID: 7538032
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Serologic responses to hepatitis C virus in solid organ transplant recipients.
    Preiksaitis JK; Cockfield SM; Fenton JM; Burton NI; Chui LW
    Transplantation; 1997 Dec; 64(12):1775-80. PubMed ID: 9422419
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Incidence and influence of GB virus C and hepatitis C virus infection in patients undergoing bone marrow transplantation.
    Akiyama H; Nakamura N; Tanikawa S; Sakamaki H; Onozawa Y; Shibayama T; Tanaka S; Tsuda F; Okamoto H; Miyakawa Y; Mayumi M
    Bone Marrow Transplant; 1998 Jun; 21(11):1131-5. PubMed ID: 9645576
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Antibodies to hepatitis C virus in prospectively followed patients with posttransfusion hepatitis.
    Lee SD; Hwang SJ; Lu RH; Lai KH; Tsai YT; Lo KJ
    J Infect Dis; 1991 Jun; 163(6):1354-7. PubMed ID: 1645386
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Anti-hepatitis C antibodies and non-A, non-B post-transfusion hepatitis in The Netherlands.
    van der Poel CL; Reesink HW; Lelie PN; Leentvaar-Kuypers A; Choo QL; Kuo G; Houghton M
    Lancet; 1989 Aug; 2(8658):297-8. PubMed ID: 2569103
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Seropositivity to hepatitis C virus in Tunisian haemodialysis patients.
    Jemni S; Ikbel K; Kortas M; Mahjoub J; Ghachem L; Bidet JM; Boukef K
    Nouv Rev Fr Hematol (1978); 1994 Oct; 36(5):349-51. PubMed ID: 7534398
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hepatitis C virus infection and bone marrow transplantation: a cohort study with 10-year follow-up.
    Strasser SI; Myerson D; Spurgeon CL; Sullivan KM; Storer B; Schoch HG; Kim S; Flowers ME; McDonald GB
    Hepatology; 1999 Jun; 29(6):1893-9. PubMed ID: 10347135
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prevention of posttransfusion hepatitis B and C by screening for antibody to hepatitis C virus and antibody to HBcAg.
    Chung HT; Lee JS; Lok AS
    Hepatology; 1993 Nov; 18(5):1045-9. PubMed ID: 7693569
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hepatitis B, Hepatitis C, and Human Immune deficiency Virus Seroconversion Positivity Rates and Their Potential Risk Factors Among Patients on Maintenance Hemodialysis in Cameroon.
    Halle MP; Choukem SP; Kaze FF; Ashuntantang G; Tchamago V; Mboue-Djieka Y; Temfack E; Luma HN
    Iran J Kidney Dis; 2016 Sep; 10(5):304-309. PubMed ID: 27721229
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Antibodies to hepatitis C virus (HCV) in chronic renal failure (CRF) patients on conservative therapy: prevalence, risk factors and relationship to liver disease.
    Fabrizi F; Marcelli D; Bacchini G; Guarnori I; Erba G; Locatelli F
    Nephrol Dial Transplant; 1994; 9(7):780-4. PubMed ID: 7526275
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A controlled study of hepatitis C transmission by organ transplantation. The New England Organ Bank Hepatitis C Study Group.
    Pereira BJ; Wright TL; Schmid CH; Levey AS
    Lancet; 1995 Feb; 345(8948):484-7. PubMed ID: 7532254
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prevalence and serological manifestation of hepatitis C virus infection in patients with hepatitis non-A, non-B: a follow-up study.
    Goeser T; Müller HM; Solbach C; Gmelin K; Kurzen F; Kommerell B; Theilmann L
    Presse Med; 1994 Apr 30-May 7; 23(17):793-6. PubMed ID: 8078836
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of hepatitis C infection and renal transplantation on survival in end-stage renal disease. The New England Organ Bank Hepatitis C Study Group.
    Pereira BJ; Natov SN; Bouthot BA; Murthy BV; Ruthazer R; Schmid CH; Levey AS
    Kidney Int; 1998 May; 53(5):1374-81. PubMed ID: 9573555
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The natural history of community-acquired hepatitis C in the United States. The Sentinel Counties Chronic non-A, non-B Hepatitis Study Team.
    Alter MJ; Margolis HS; Krawczynski K; Judson FN; Mares A; Alexander WJ; Hu PY; Miller JK; Gerber MA; Sampliner RE
    N Engl J Med; 1992 Dec; 327(27):1899-905. PubMed ID: 1280771
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.